Clinical Trials in Chicago

Showing 18901-18920 of 20,493 trials

Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failure (FHF)

NCT00832728

This is a multicenter, open-label, randomized, concurrent control study of subjects with FHF. Subjects meeting the eligibility requirements of the study will be randomly assigned in a 2:1 ratio to receive either standard medical therapy for FHF plus the ELAD® system, or standard medical therapy alone, with the latter defined as conventional therapy for FHF determined to be clinically appropriate by the treating physician.

Fulminant Hepatic Failure

Vital Therapies, Inc.Started Mar 2009

La Jolla, California, United States • Los Angeles, California, United States • San Francisco, California, United States +9 more locations

COMPLETEDPhase 22.2 miles

A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia

NCT00569972

To demonstrate efficacy and characterize the dose response relationship of PD 0200390 on subjective wake after sleep onset in subjects with primary insomnia.

Insomnia

Pfizer682 participantsStarted Oct 2007

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +81 more locations

Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failure (FHF)

A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia

Find Trials by Condition in Chicago

Calfactant for Direct Acute Respiratory Distress Syndrome

Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis

Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age

Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy

Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

Comparison Study for Safety and Efficacy of Two Devices for the Treatment of the Great Saphenous Vein

CRESTOR Athero Imaging Head to Head IVUS Study

Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer

A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency

ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)

Peripheral Facilitated Antegrade Steering Technique in Chronic Total Occlusions

SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth

Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer

Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%

Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura

Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors

Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis